Omnic Ocas 0.4 mg tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Omnic Ocas 0.4 mg tablets, covering 2025-08-08 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions [Phase 1]